CN103012305B - 一种福沙匹坦中间体的制备方法 - Google Patents
一种福沙匹坦中间体的制备方法 Download PDFInfo
- Publication number
- CN103012305B CN103012305B CN201110305806.8A CN201110305806A CN103012305B CN 103012305 B CN103012305 B CN 103012305B CN 201110305806 A CN201110305806 A CN 201110305806A CN 103012305 B CN103012305 B CN 103012305B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- stirring
- normal hexane
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110305806.8A CN103012305B (zh) | 2011-09-23 | 2011-09-23 | 一种福沙匹坦中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110305806.8A CN103012305B (zh) | 2011-09-23 | 2011-09-23 | 一种福沙匹坦中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103012305A CN103012305A (zh) | 2013-04-03 |
CN103012305B true CN103012305B (zh) | 2016-08-17 |
Family
ID=47961464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110305806.8A Active CN103012305B (zh) | 2011-09-23 | 2011-09-23 | 一种福沙匹坦中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103012305B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447607B (zh) * | 2014-12-12 | 2017-02-22 | 瑞阳制药有限公司 | 阿瑞匹坦中间体的制备方法 |
CN104557760A (zh) * | 2015-01-28 | 2015-04-29 | 武汉励合生物医药科技有限公司 | 阿瑞吡坦中间体的制备方法 |
CN108929284B (zh) * | 2017-05-27 | 2022-08-02 | 上海彩迩文生化科技有限公司 | 吗啉酮类异构体的分离方法 |
CN109516964B (zh) * | 2017-09-19 | 2022-05-31 | 鲁南制药集团股份有限公司 | 一种阿瑞匹坦中间体的制备方法 |
CN109694360A (zh) * | 2018-12-28 | 2019-04-30 | 凯瑞斯德生化(苏州)有限公司 | 一种阿瑞匹坦中间体的制备方法 |
CN110483436B (zh) * | 2019-09-19 | 2021-07-16 | 西安凯立新材料股份有限公司 | 一种制备4-苄基-2-羟基-吗啉-3-酮的方法 |
CN112500363A (zh) * | 2020-12-23 | 2021-03-16 | 中山奕安泰医药科技有限公司 | 阿瑞匹坦中间体的精制方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094323A1 (en) * | 2000-06-08 | 2001-12-13 | Merck & Co., Inc. | Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-1,4-oxazin-3-one |
CN1436178A (zh) * | 2000-06-08 | 2003-08-13 | 麦克公司 | (2R,2-α-R,3a)-2-[1-(3,5-双(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)-1,4-噁嗪的合成方法 |
US20030215456A1 (en) * | 2001-10-02 | 2003-11-20 | Sui-Long Yao | Method of treating cancer |
-
2011
- 2011-09-23 CN CN201110305806.8A patent/CN103012305B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094323A1 (en) * | 2000-06-08 | 2001-12-13 | Merck & Co., Inc. | Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-1,4-oxazin-3-one |
CN1436178A (zh) * | 2000-06-08 | 2003-08-13 | 麦克公司 | (2R,2-α-R,3a)-2-[1-(3,5-双(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)-1,4-噁嗪的合成方法 |
US20030215456A1 (en) * | 2001-10-02 | 2003-11-20 | Sui-Long Yao | Method of treating cancer |
Non-Patent Citations (1)
Title |
---|
Efficient Synthesis of NK1 Receptor Antagonist Aprepitant Using a Crystallization-Induced Diastereoselective Transformation;Karel M.J.Brands,等;《JACS》;20030130;第125卷(第8期);第2130-2133页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103012305A (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103012305B (zh) | 一种福沙匹坦中间体的制备方法 | |
ES2631203T3 (es) | Sal hemifumarato del ácido 1-[4-[1-(4-ciclohexil-3-trifluorometil-benciloxiimino)-etil]-2-etil-bencil]-azetidina-3-carboxílico para su uso en el tratamiento de enfermedades mediadas por linfocitos | |
CN103030668B (zh) | 一种制备福沙匹坦二甲葡胺的方法 | |
WO2017202365A1 (zh) | 一种三氟甲基取代的吡喃衍生物制备方法 | |
WO2021150806A1 (en) | Heterocyclic compounds as anti-viral agents | |
CN110642874B (zh) | 一类细胞坏死抑制剂及其制备方法和用途 | |
CN115353508B (zh) | 5-吡啶-1h-吲唑类化合物、药物组合物和应用 | |
CN104478877A (zh) | 制备雷迪帕韦中间体的方法 | |
CN102351778A (zh) | 一种盐酸阿比朵尔的制备方法 | |
CN107383012B (zh) | 含二环的咪唑醇衍生物 | |
JP2019509295A (ja) | レチノイン酸系化合物、その製造方法、中間体及び応用 | |
CN103897025A (zh) | 一种匹多莫德的制备方法 | |
CN102977142B (zh) | 福沙匹坦二甲葡胺的制备方法 | |
WO2017202357A1 (zh) | 一种三氟甲基取代的吡喃衍生物的制备方法 | |
JP7096559B2 (ja) | トリプトリド誘導体およびその製造方法と使用 | |
CN114181198A (zh) | 嘧啶衍生物类己酮糖激酶抑制剂及其用途 | |
CN103183708A (zh) | 福沙吡坦二甲葡胺的制备方法 | |
CN104364253A (zh) | 作为kat ii抑制剂的三环化合物 | |
EP2922833A1 (en) | Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | |
CN110922415A (zh) | 一种新型抗肿瘤活性化合物的合成与应用 | |
CN103113408B (zh) | 一种制备磷霉素左磷右胺盐的新方法 | |
JP5987102B1 (ja) | トリアリールメタン組成物,眼膜染色のための染色組成物 | |
CN108440374B (zh) | 一种阿西美辛的制备方法 | |
US11091508B2 (en) | Fosaprepitant phosphate intermediate and preparation method therefor | |
CN110240570A (zh) | 一种帕瑞昔布钠杂质的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |